NO924166L - Nye ftalaziner som i 1-stilling inneholder en eter- ellertioetergruppe og fremgangsmaate for fremstilling derav - Google Patents

Nye ftalaziner som i 1-stilling inneholder en eter- ellertioetergruppe og fremgangsmaate for fremstilling derav

Info

Publication number
NO924166L
NO924166L NO92924166A NO924166A NO924166L NO 924166 L NO924166 L NO 924166L NO 92924166 A NO92924166 A NO 92924166A NO 924166 A NO924166 A NO 924166A NO 924166 L NO924166 L NO 924166L
Authority
NO
Norway
Prior art keywords
residue
substituted
phenyl
alkyl
pyrldyl
Prior art date
Application number
NO92924166A
Other languages
English (en)
Norwegian (no)
Other versions
NO924166D0 (no
Inventor
Gerhard Scheffler
Ilona Fleischhauer
Bernhard Kutscher
Juergen Engel
Stefan Szelenyi
Ulrich Werner
Original Assignee
Asta Medica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica Ag filed Critical Asta Medica Ag
Publication of NO924166D0 publication Critical patent/NO924166D0/no
Publication of NO924166L publication Critical patent/NO924166L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30Phthalazines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30Phthalazines
    • C07D237/32Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D453/00Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Cosmetics (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO92924166A 1991-10-31 1992-10-29 Nye ftalaziner som i 1-stilling inneholder en eter- ellertioetergruppe og fremgangsmaate for fremstilling derav NO924166L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4135910 1991-10-31

Publications (2)

Publication Number Publication Date
NO924166D0 NO924166D0 (no) 1992-10-29
NO924166L true NO924166L (no) 1993-05-03

Family

ID=6443832

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92924166A NO924166L (no) 1991-10-31 1992-10-29 Nye ftalaziner som i 1-stilling inneholder en eter- ellertioetergruppe og fremgangsmaate for fremstilling derav

Country Status (20)

Country Link
US (1) US5354750A (cs)
EP (1) EP0539805B1 (cs)
JP (1) JPH05222002A (cs)
KR (1) KR930007914A (cs)
CN (1) CN1071916A (cs)
AT (1) ATE157656T1 (cs)
AU (1) AU660726B2 (cs)
BR (1) BR9204187A (cs)
CA (1) CA2081819A1 (cs)
DE (2) DE59208852D1 (cs)
DK (1) DK0539805T3 (cs)
ES (1) ES2108066T3 (cs)
FI (1) FI924934L (cs)
GR (1) GR3025141T3 (cs)
HU (2) HUT62866A (cs)
IL (1) IL103601A0 (cs)
MX (1) MX9206245A (cs)
NO (1) NO924166L (cs)
TW (1) TW211563B (cs)
ZA (1) ZA928420B (cs)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9226573D0 (en) * 1992-12-21 1993-02-17 Ici Plc Heterocyclic compounds
US6291425B1 (en) 1999-09-01 2001-09-18 Guilford Pharmaceuticals Inc. Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage
US6635642B1 (en) 1997-09-03 2003-10-21 Guilford Pharmaceuticals Inc. PARP inhibitors, pharmaceutical compositions comprising same, and methods of using same
US20020028813A1 (en) * 1997-09-03 2002-03-07 Paul F. Jackson Thioalkyl compounds, methods, and compositions for inhibiting parp activity
US6426415B1 (en) 1997-09-03 2002-07-30 Guilford Pharmaceuticals Inc. Alkoxy-substituted compounds, methods and compositions for inhibiting parp activity
US6514983B1 (en) 1997-09-03 2003-02-04 Guilford Pharmaceuticals Inc. Compounds, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage
US6346536B1 (en) 1997-09-03 2002-02-12 Guilford Pharmaceuticals Inc. Poly(ADP-ribose) polymerase inhibitors and method for treating neural or cardiovascular tissue damage using the same
US6197785B1 (en) 1997-09-03 2001-03-06 Guilford Pharmaceuticals Inc. Alkoxy-substituted compounds, methods, and compositions for inhibiting PARP activity
US6395749B1 (en) 1998-05-15 2002-05-28 Guilford Pharmaceuticals Inc. Carboxamide compounds, methods, and compositions for inhibiting PARP activity
US6387902B1 (en) 1998-12-31 2002-05-14 Guilford Pharmaceuticals, Inc. Phenazine compounds, methods and pharmaceutical compositions for inhibiting PARP
AU2001264595A1 (en) 2000-05-19 2001-12-03 Guilford Pharmaceuticals Inc. Sulfonamide and carbamide derivatives of 6(5h)phenanthridinones and their uses
WO2002044157A2 (en) * 2000-12-01 2002-06-06 Iconix Pharmaceuticals, Inc. Parb inhibitors
GB0507298D0 (en) 2005-04-11 2005-05-18 Novartis Ag Organic compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2484029A (en) * 1945-12-21 1949-10-11 Ciba Pharm Prod Inc Hydrazine derivatives of pyridazine compounds
US3882119A (en) * 1970-01-27 1975-05-06 Lepetit Spa Tetracyclic substituted phthalazine compounds
IL48319A0 (en) * 1974-10-26 1975-12-31 Merck Patent Gmbh Araliphatic nitrogen compounds and a process for their preparation
JPH01261386A (ja) * 1988-04-11 1989-10-18 Nisshin Flour Milling Co Ltd 新規な2―ピリジルメチルチオ誘導体及びそれを含有する抗潰瘍剤

Also Published As

Publication number Publication date
CA2081819A1 (en) 1993-05-01
FI924934A7 (fi) 1993-05-01
AU2747192A (en) 1993-05-06
HU9203431D0 (en) 1993-01-28
FI924934A0 (fi) 1992-10-30
ES2108066T3 (es) 1997-12-16
AU660726B2 (en) 1995-07-06
DK0539805T3 (da) 1998-03-23
ATE157656T1 (de) 1997-09-15
BR9204187A (pt) 1993-05-04
HUT62866A (en) 1993-06-28
MX9206245A (es) 1993-05-01
DE4234933A1 (de) 1993-05-06
FI924934L (fi) 1993-05-01
TW211563B (cs) 1993-08-21
JPH05222002A (ja) 1993-08-31
DE59208852D1 (de) 1997-10-09
US5354750A (en) 1994-10-11
NO924166D0 (no) 1992-10-29
IL103601A0 (en) 1993-03-15
EP0539805B1 (de) 1997-09-03
ZA928420B (en) 1993-05-14
HU211863A9 (en) 1995-12-28
CN1071916A (zh) 1993-05-12
KR930007914A (ko) 1993-05-20
EP0539805A1 (de) 1993-05-05
GR3025141T3 (en) 1998-02-27

Similar Documents

Publication Publication Date Title
NO924166L (no) Nye ftalaziner som i 1-stilling inneholder en eter- ellertioetergruppe og fremgangsmaate for fremstilling derav
DK359289D0 (da) 4-oxoquinolin-3-carboxylsyrederivater og fremgangsmaade til fremstilling deraf samt deres anvendelse
MY102866A (en) Amide derivatives.
NO996108L (no) 9-oksinerytromycinderivater
NO980919L (no) 8-azabicyklo(3.2.1)okt-2-ene derivater, og deres anvendelse til fremstilling av et legemiddel
HUP0105190A2 (hu) Ketolid antibiotikumok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
NO983493L (no) Nye benzimidazol-, benzoksazol- og benzotiazolforbindelser, fremgangsmÕte ved fremstilling derav og farmas°ytiske sammensetninger inneholdende slike
NO944930L (no) Hemming av dysfunksjonell uterin blödning
SE9701304D0 (sv) Compounds
MY131641A (en) Indoline derivatives, process of preparation and use
NO961000L (no) Piperidinderivater, fremgangsmåte for fremstilling derav og medikament og preparat inneholdende slike
NZ516100A (en) Streptogramin derivatives, preparation and compositions containing them
NO178968C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive aminopyrimidin-karboksamidderivater
NO944926L (no) Fremgangsmåter for å inhibere myeloperoksidaseaktivitet
NO172437C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrimidindionforbindelser
NO20022123L (no) Osoksazolderivater for anvendelse som inhibitorer for fosfodiesterase VII
YU10402A (sh) Supstituisani 3-fenil-5-alkoksi-1,3,4-oksidiazol-2-oni i njihova upotreba za proizvodnju leka
MY105571A (en) Herbicidal 1,3,5-triazin-2-ylaminocarbonylamino- sulfonylbenzoic esters, the preparation and use thereof.
HUT44574A (en) Process for preparing 10beta-alkinyl-estrene derivatives
MY126743A (en) Aminoethylphenoxyacetic acid derivatives and agents for relieving pain and promoting the removal of calculi in urolithiasis
AU639154B2 (en) New imidazole compounds, a process for the preparation thereof, and pharmaceutical compositions containing them
NO930353L (no) Enzosyrederivater, fremgangsmaate for deres fremstilling og anvendelse derav
NO944513D0 (no) Oksadiazolderivater, fremgangsmåte for deres fremstilling og anvendelse
DK164057C (da) Oe5,6aa-cis-1,3-oxathianderivater og fremgangsmaade til deres fremstilling og farmaceutisk middel indeholdende et saadant derivat
NO911081L (no) Fremgangsmaate for fremstilling av substituerte puriner, og deres anvendelse som antivirale midler.